CBT for Anxiety Disorder in Children With Co-morbid ASD

Overview

Children with Autism Spectrum Disorder (ASD) often have other difficulties as a result of the disorder. Up to half of the children with ASD are thought to suffer with anxiety in a way that interferes with their wellbeing and every day functioning. In this project the investigators will study the effect of the group program The Cool Kids Anxiety Program: Autism Spectrum Disorder Adaptation (Cool Kids ASD) – an anxiety treatment program specific developed for children with ASD. The investigators expect a decrease in the overall anxiety level together with an increase in the ability of handling anxiety.

Full Title of Study: “Cognitive Behavioural Therapy for Anxiety Disorder in Children With Co-morbid Autism Spectrum Disorder”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: September 2019

Detailed Description

The primary objective is to investigate the effect of a manualised Cognitive Behavioural Therapy (CBT) programme The Cool Kids Anxiety Program: Autism Spectrum Disorder Adaptation (Cool Kids ASD) for anxiety disorder adapted to children with Autism Spectrum Disorder (ASD) in a waitlist controlled design. The investigators will investigate treatment effects on anxiety diagnosis and anxiety symptoms. Further, the investigators will investigate outcomes related to general functioning, co-morbid psychiatric disorders (Obsessive-Compulsive Disorder (OCD), hyperkinetic disorder and depression) and level of ASD symptoms (social and communicative skills).

Interventions

  • Behavioral: CBT
    • The group based manualised CBT intervention consists of The Cool Kids Anxiety Program: Autism Spectrum Disorder Adaptation (Cool Kids ASD).

Arms, Groups and Cohorts

  • Active Comparator: CBT
  • No Intervention: WL

Clinical Trial Outcome Measures

Primary Measures

  • Anxiety Disorders Interview Schedule for DSM-IV: Parent & Child interview schedule (ADIS/CP).
    • Time Frame: Change from baseline interview results at 14 weeks
    • ADIS/CP is a structured interview involving both child and parents designed to assess for current episodes of anxiety disorders, and to permit differential diagnosis among the anxiety disorders according to DSM-IV criteria.
  • Anxiety Disorders Interview Schedule for DSM-IV: Parent & Child interview schedule (ADIS/CP).
    • Time Frame: Change from baseline interview results at 3 months
    • ADIS/CP is a structured interview involving both child and parents designed to assess for current episodes of anxiety disorders, and to permit differential diagnosis among the anxiety disorders according to DSM-IV criteria.

Secondary Measures

  • Spence Children’s Anxiety Scale (SCAS),
    • Time Frame: Change from baseline results at 14 weeks
    • SCAS is a questionnaire for children and parents assessing the severity of anxiety symptoms broadly in line with the dimensions of anxiety disorder proposed by the DSM-IV. The scale assesses six domains of anxiety including generalized anxiety, panic/agoraphobia, social phobia, separation anxiety, obsessive-compulsive disorder and physical injury fears.
  • Spence Children’s Anxiety Scale (SCAS),
    • Time Frame: Change from baseline results at 3 months
    • SCAS is a questionnaire for children and parents assessing the severity of anxiety symptoms broadly in line with the dimensions of anxiety disorder proposed by the DSM-IV. The scale assesses six domains of anxiety including generalized anxiety, panic/agoraphobia, social phobia, separation anxiety, obsessive-compulsive disorder and physical injury fears.
  • Children’s Anxiety Life Inference Scale (CALIS)
    • Time Frame: Change from baseline results at 14 weeks
    • CALIS is designed to assess life interference attributed to fears and worries from child and parent perspectives. The measure targets interference on the child’s life and on the parent’s/family’s life.
  • Children’s Anxiety Life Inference Scale (CALIS)
    • Time Frame: Change from baseline results at 3 months
    • CALIS is designed to assess life interference attributed to fears and worries from child and parent perspectives. The measure targets interference on the child’s life and on the parent’s/family’s life.
  • Children’s Automatic Thoughts Scale (CATS).
    • Time Frame: Change from baseline results at 14 weeks
    • CATS is a developmentally sensitive, general measure of negative self-statements across both internalizing and externalizing problems. Four separate subscales of cognitive content are assessed including physical threat, social threat, personal failure, and hostility.
  • Children’s Automatic Thoughts Scale (CATS).
    • Time Frame: Change from baseline results at 3 months
    • CATS is a developmentally sensitive, general measure of negative self-statements across both internalizing and externalizing problems. Four separate subscales of cognitive content are assessed including physical threat, social threat, personal failure, and hostility.

Participating in This Clinical Trial

Inclusion Criteria

  • ASD – Anxiety (not necessary diagnosed) Exclusion Criteria:

  • IQ under 70 – Not meeting diagnostic criteria for primary anxiety diagnosis on ADIS – Active psychosis – Untreated ADHD – Families not able to follow program

Gender Eligibility: All

Minimum Age: 7 Years

Maximum Age: 14 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of Aarhus
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.